Join this session dedicated to "Advancing Percutaneous Coronary Intervention for Chronic Total Occlusion". Explore the latest advances, evidence-based practices and transformative techniques that leverage intracoronary imaging to improve decision-making in percutaneous coronary intervention for chronic total occlusion. Be inspired by leading experts and collaborate with other...

Explore the intricacies of tricuspid and pulmonary valve disorders, as we delve into the challenges faced by the right heart in this session: discover the groundbreaking approach of triple percutaneous valvular therapy in patient with congenital heart disease, learn about innovative strategies for managing massive atrial...

Consult this session to find out more about common iliac CTO PTA via radial approach, transbrachial intervention of bilateral common iliac arteries, shifting of thrombus across the aortoiliac bifurcation during iliac stenting, and much more!

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Paris, France, 21 May 2019. Severe symptomatic aortic stenosis, a degenerative disease-causing calcification and immobility of the aortic valve leaflets leading to left ventricular outflow obstruction, is the most common valve lesion leading to intervention in Europe and the USA. Symptoms include heart failure, syncope and...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...